Researchers connect the dots between cause-effect events in Alzheimer’s disease
Peer-Reviewed Publication
Updates every hour. Last Updated: 1-Jun-2026 05:15 ET (1-Jun-2026 09:15 GMT/UTC)
A new study led by the Harvard Pilgrim Health Care Institute finds that mental health care gaps for U.S. children remain stark: one in five households reported a child needing treatment, yet nearly a quarter didn’t receive it, and many who did still struggled to access care.
In the largest population-based analysis of CKM syndrome to date, researchers from Fuwai Hospital, Chinese Academy of Medical Sciences, leveraged data from over 764,000 adults across 31 provinces of Chinese mainland. The study confirms a stepwise increase in all-cause and cause-specific mortality with advancing CKM stages and reveals profound risk heterogeneity driven primarily by CKD status and its KDIGO-based risk stratification—especially within stage 2, where CKD confers significantly higher mortality than isolated metabolic abnormalities
Researchers from the NeuroAD group (Neuropathology of Alzheimer’s Disease) within the Department of Cell Biology, Genetics and Physiology at the University of Málaga, also affiliated with IBIMA–BIONAND Platform and CIBERNED, have made a pioneering breakthrough in the fight against this disease by identifying astrocytes as a promising cellular target for the development of future therapies.